HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients.

Abstract
T-cell immunoglobulin domain and mucin domain-3(TIM-3) is an activation induced inhibitory molecule involved in immune tolerance and is recently reported to induce T cell exhaustion which is mediated by carcinoembryonic antigen cell adhesion molecule 1(CEACAM1), another well-known molecule expressed on activated T cells and involved in T cell inhibition. To investigate the expression of TIM-3 and CEACAM1 on circulating CD8+ T cells and tumor infiltrating lymphocytes (TILs), 65 diagnosed colorectal cancer (CRC) patients and 38 healthy controls were enrolled in this study and the results showed that TIM-3 and CEACAM1 were both highly expressed on circulating CD8+ T cells in CRC patients and elevated on TILs compared with paraneoplastic T cells. Furthermore, TIM-3+CEACAM1+ CD8+ T cells represented the most dysfunctional population with the least IFN-γ production. In addition, the expressions of TIM-3 and CEACAM1 were correlated with advanced stage and could be independent risk factors for CRC. We for the first time to our knowledge suggested that co-expression of TIM-3 and CEACAM1 can mediate T cell exhaustion and may be potential biomarkers for CRC prediction, highlighting the possibility of being immunotherapy targets.
AuthorsYang Zhang, Pengcheng Cai, Lei Li, Liang Shi, Panpan Chang, Tao Liang, Qianqian Yang, Yang Liu, Lin Wang, Lihua Hu
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 43 Pg. 210-218 (Feb 2017) ISSN: 1878-1705 [Electronic] Netherlands
PMID28038383 (Publication Type: Journal Article)
CopyrightCopyright © 2016 Elsevier B.V. All rights reserved.
Chemical References
  • Antigens, CD
  • Biomarkers, Tumor
  • CD66 antigens
  • Cell Adhesion Molecules
  • HAVCR2 protein, human
  • Hepatitis A Virus Cellular Receptor 2
  • Interferon-gamma
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD (metabolism)
  • Biomarkers, Tumor (metabolism)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cell Adhesion Molecules (metabolism)
  • Colorectal Neoplasms (diagnosis, pathology)
  • Female
  • Hepatitis A Virus Cellular Receptor 2 (metabolism)
  • Humans
  • Interferon-gamma (metabolism)
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Risk Factors
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: